Skip to content

Two novel ‘enhancer’ drugs boost protease inhibitors as much as ritonavir

Switching from Kaletra to raltegravir improves lipid profiles at the risk of viral rebound

When to start HIV treatment: cohort studies disagree on how early

Once-daily darunavir approved in Europe for patients starting HIV treatment

HIV treatment during pregnancy does not increase risk of birth abnormalities – even when efavirenz included

Simultaneous treatment of HIV and TB improves survival

The NAM treatment survey

Adherence and long-term treatment success

Excellent adherence in Africa due to social networks